Funding Received
$45 Million in 3 Rounds from 4 Investors
Most Recent Funding
$4 Million Debt Financing on April 7, 2014
Headquarters:
Ann Arbor, MI
Description:
Lycera engages in the development of small-molecule immunomodulators for the treatment of patients with autoimmune diseases.
Categories:
Biotechnology
Website:
http://www.lycera.com

Company Details

Update
Founded:
2006
Contact:
Employees:
1 in CrunchBase

Lycera isa preclinical-stage biopharma company focused on small molecule immunomodulators for the treatment of rheumatoid arthritis, lupus erythematosis and inflammatory bowel disease Lycera's first-in-class drugs are designed to treat immune disorders. Lycera’s technology platforms include proprietary small molecules that modulate a target, which is central to cellular bioenergetics along with molecules that target the Th17 pathway.

Drugs that emerge from the Lycera pipeline will represent first-in-class agents that have the potential for first-in-class oral efficacy without the adverse effects of current standard-of-care antiproliferative and immunosuppressive agents.

Current Team (1)

Update

Funding Rounds (3) - $45M

Update

Investors (4)

Update
  • Bb3d6fbd0e442789b59061f392f8ad0d

    InterWest Partners

    InterWest invests an average of about $7 - 15 million over the span of their involvement with...
  • 920ef1c9e2d2a1b871893ee51107f97c

    ARCH Venture Partners

    ARCH invests primarily in companies co-founded with leading scientists and entrepreneurs,...
  • 59ee59b2af63dbcc39c2fd4e9edf4c8b

    EDF Ventures

    EDF has cultivated a deep and productive network. They have put their network to work for present...
  • Ecd7e24dcc0b6edd2833c7a732da1b25

    Clarus Ventures

    Clarus Ventures is a life sciences venture capital firm.

Offices/Locations (1)

Update
  • Lycera

    2800 Plymouth Rd.

    NCRC, Building 26

    Ann Arbor, MI 48109

    USA

Images (1)

Update
  • F98e96fb40006b019e506defd40077da